Filter
358
Filtered Results: 358
Text search:
dried
blood
spots
Featured
Recommendations
38
New Publications
146
Language
Document type
No document type
253
Studies & Reports
41
Guidelines
31
Manuals
12
Training Material
8
Strategic & Response Plan
6
Fact sheets
4
Brochures
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
37
Nepal
13
Uganda
13
Malawi
12
Tanzania
11
South Africa
11
Sierra Leone
10
Zambia
10
Nigeria
9
Ethiopia
9
Kenya
7
Lesotho
7
Ghana
6
Bangladesh
6
Namibia
6
Liberia
6
Rwanda
5
Zimbabwe
5
Global
5
Africa
5
Congo, Democratic Republic of
5
Syria
4
Asia
4
West and Central Africa
4
East and Southern Africa
4
Mozambique
3
Tajikistan
2
Philippines
2
South–East Asia Region
2
South Sudan
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
Ukraine
1
Turkey
1
Togo
1
Cameroon
1
Albania
1
Senegal
1
Burkina Faso
1
Afghanistan
1
Cambodia
1
Venezuela
1
Jordan
1
Germany
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Bolivia
1
Lebanon
1
Papua New Guinea
1
Sri Lanka
1
Russia
1
Sudan
1
Angola
1
Bhutan
1
Botswana
1
Indonesia
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
192
Clinical Guidelines
27
Women & Child Health
20
Pharmacy & Technologies
12
Public Health
11
Capacity Building
10
Key Resources
8
Toolboxes
HIV
59
Ebola
14
Rapid Response
11
TB
10
Conflict
10
COVID-19
8
NTDs
7
Mental Health
6
Caregiver
6
Pharmacy
6
Refugee
5
Cholera
5
AMR
3
Natural Hazards
2
NCDs
2
Polio
2
Global Health Education
2
Specific Hazards
1
Planetary Health
1
Zika
1
3rd Edition – July 2017
www.msfaccess.org
UNAIDS Joint United Nations Programme on HIV/AIDS
Módulo 1
Clínico
Julho de 2017
Módulo 1: Clínico. Este módulo é destinado a profissionais de saúde como médicos, enfermeiros e auxiliares e traz um resumo sobre como prover a PrEP de forma segura e efetiva, abordando vários aspectos: triagem de pessoas com risco substancial de contr...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
23 March 2021
The meeting addressed the last key area, that is, determining the best method or combination of diagnostic methods for a control programme for S. stercoralis infections in humans.
Dr Montresor’s presentation highlighted that while there is currently no “gold standard” for the...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
This document synthesizes key elements of the World Health Organization (WHO) normative guidance on health policy and system support for community health worker (CHW) programmes and their application for HIV programmes. Building on relevant elements of HIV guidelines, tools and evidence identified b...
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in ...
Final Report
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec
le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les
populations sous TAR. Bien que la résistance au DT...
A medida que el tratamiento antirretrovírico con dolutegravir se extiende a más personas que viven con el VIH en el
mundo, adquiere más importancia estimar la frecuencia con que surge la farmacorresistencia adquirida a este
antirretrovírico en las poblaciones tratadas con esquemas que lo conti...
Este relatório apresenta informações sobre o conhecimento, atitutes e comportamentos em relação ao HIV/SIDA, a prevalência da malária e de indicadores básicos de saúde da mulher e da criança em Moçambique, tal como recolhida através do IMASIDA 2015 que foi realizado no âmbito do program...
A Situational Assessment and Five-YearAction Plan for the Africa CDC Strengthening Regional Public Health Institutions and Capacity for Surveillance and Response Program
The 2018 NDHS is a national sample survey that provides up-to-date information on demographic and health indicators. The sample was selected using a stratified, two-stage cluster design, with enumeration areas (EAs) as the sampling units for the first stage. The second stage was a complete listing o...
Malgré les progrès récents vers la mise au point d’un traitement hautement efficace et abordable contre le virus de l’hépatite C, beaucoup de personnes infectées par ce virus ne connaissent pas leur statut. L’Organisation mondiale de la Santé (OMS) estime qu’en 2019, 58 millions ...
